Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Introducing Palliative Care (PC) Within the Treatment of End Stage Liver Disease (ESLD): A Cluster Randomized Controlled Trial

NCT03540771 is registered in ClinicalTrials.gov with Albert Einstein Healthcare Network as lead sponsor.

NCT NCT03540771
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03540771 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Introducing Palliative Care (PC) Within the Treatment of End Stage Liver Disease (ESLD): A Cluster Randomized Controlled Trial
Lead sponsor
Albert Einstein Healthcare Network
Phase
Not applicable
Overall status
Completed
Start date
January 30, 2019
Completion date
August 30, 2025
Enrollment
1,494 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

decompensated cirrhosis of liver, end stage liver disease